LIMN Latest Press Releases

-- August 24, 2026 --

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy Globe Newswire 8:00 AM

-- August 18, 2026 --

Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock Globe Newswire 4:01 PM

-- August 13, 2026 --

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement Globe Newswire 7:15 AM

-- June 30, 2026 --

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline Globe Newswire 4:30 PM

-- June 3, 2026 --

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds Globe Newswire 8:30 AM

-- May 21, 2026 --

Liminatus Pharma Announces Nasdaq Delisting Notification Globe Newswire 8:28 PM

Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline Globe Newswire 8:04 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software